Patient-related barriers such as inability to inject, monitor, or titrate the insulin dose, weight gain, hypoglycemia, and lack of awareness of uncontrolled diabetes can be bridged with patient education and training, support and counselling, and social marketing. This evidence concerns the gene INS and diabetes mellitus.